Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Honeywell International Inc (HON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Honeywell International Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while Honeywell International Inc trades at $208.4 (market cap $65.70B). The key difference: Honeywell International Inc is far larger — about 2.1× GE HealthCare Technologies Inc. Common Stock's market cap, and Honeywell International Inc pays the higher dividend (1.35%). Which is the better fit depends on your goals.
| GEHC | HON | |
|---|---|---|
Market Cap | $31.07B | $65.70B |
Volume | 3,443,020 | 1,861,268 |
Sector | Health | Industrials |
52-Week High | $88.16 | $248.79 |
52-Week Low | $59.48 | $188.14 |
Enterprise Value | $39.53B | $90.49B |
Dividend Yield | 0.23% | 1.35% |
Typical Hold Time | — | 91 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Honeywell International (HON) trades at $207.61, down 0.97% on the day, as technical indicators show bearish momentum despite strong fundamentals. The company has consistently beaten earnings estimates in recent quarters with Q2 2026 EPS of $1.95 exceeding expectations of $1.83. Recent news highlights Honeywell's $300 million contract win for the Dangote refinery project and the company's strategic focus on automation following its corporate restructuring into three separate entities.
Honeywell presents a compelling value opportunity with attractive valuation multiples (P/E of 7.97, EV/EBITDA of 6.74) and strong profitability metrics (ROE 47.43%, net margin 21.58%). However, investors face risks from increasing debt levels and the execution challenges of the corporate spin-off strategy. Analyst consensus remains bullish with a $259.25 price target representing 25% upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Honeywell International Inc
Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →
